Archives - September 12, 2019

	Data from Ozanimod Clinical Development Program in Relapsing Forms of Multiple Sclerosis to Be Presented RMS is characterized by clearly defined attacks of worsening neurologic function. These attacks — often called relapses, flare-ups or exacerbations — are followed by partial or ... Sep 12
	Aptorum Group Announces the Development of Microbiome Drug Candidate Targeting Obesity and Repurposed Drug Candidates Targeting Neuroblastoma Aptorum Group Limited (Nasdaq: APM) (“Aptorum Group”), a biopharmaceutical company focused on the development of novel therapeutics to address global unmet medical needs, announces the ... Sep 12
	Aptorum Group Has Initiated IND-Enabling Studies For Its ALS-4 Small Molecule Candidate For The Treatment Of Infections Caused By Staphylococcus Aureus Including MRSA Aptorum Group Limited (Nasdaq: APM) (“Aptorum Group”), a biopharmaceutical company focused on the development of novel therapeutics to address global unmet medical needs, announces that ... Sep 12
	CIVCO Radiotherapy Presents Proton Head & Neck Immobilization Solution at ASTRO 2019 Annual Meeting CIVCO Radiotherapy, the leading global provider of high quality, innovative, patient-centric radiotherapy solutions, will present their Universal Couchtop™ proton system along with several new ... Sep 12
	deCODE in Iceland Agrees to Sequence Half of UK Biobanks Participants deCODE genetics in Iceland has entered into an agreement with a consortium of government, charity, researchers and world leading biopharmaceutical and healthcare companies to undertake ... Sep 12
	Prominent Plastic and Cosmetic Surgeon Dr. Debraj Shome Felicitated with the Times Power Men Award Dr. Debraj Shome was conferred with the award for his noteworthy contribution as a Facial Plastic Surgeon by noted actor and producer Neha Dhupia Actor ... Sep 12
	Huawei FusionSolar Powers the World's Largest Medical Center in Jordan Huawei, a leading global ICT and network energy solutions provider, teamed up with Jordanian solar manufacturer and developer Philadelphia Solar to power the world's ... Sep 12
	Glenmark Pharmaceuticals Receives ANDA Approval for Clobetasol Propionate Foam, 0.05% (Emulsion Formulation) Glenmark Pharmaceuticals Inc., USA (Glenmark) has been granted final approval by the United States Food & Drug Administration (U.S. FDA) for Clobetasol Propionate Foam, 0.... Sep 12
	Jubilant Life Sciences Announces Appointment of Dr. Syed Kazmi as President and CEO of its New Innovative Biopharmaceutical Company in the U.S. - Jubilant Therapeutics Inc. Jubilant Life Sciences Limited has announced that Dr. Syed Kazmi, PhD, MBA, will join its new innovative biopharmaceutical company in the U.S., Jubilant Therapeutics ... Sep 12
	American Well® Applauded by Frost & Sullivan for Driving Telehealth's Next Growth Wave with Its Pioneering Strategy Based on its recent analysis of the North American telehealth services market, Frost & Sullivan recognizes Boston-based American Well® with the 2019 North America Company ... Sep 12
	Updated Results for Investigational Therapy Tepotinib Presented at WCLC 2019 Results include progression-free survival and overall survival data from Phase Ib/II INSIGHT study Phase II INSIGHT 2 study now open for enrollment for ... Sep 12
	IASLC World Conference on Lung Cancer--Summary of the Presidential Symposium Research This is a summary of research presented this morning at the International Association for the Study of Lung Cancer's World Conference on Lung Cancer. ... Sep 12
	Newly Published ROSacea COnsensus (ROSCO) Expert Recommendations Encourage Dermatologists to Upweight Burden-related Discussions, Aim For 'Complete Clearance' of Symptoms and Consider Combination Therapy For Severe Patients The rosacea treatment algorithm, developed by ROSCO in 2017, has been updated with several new recommendations including the use of combination therapy to benefit severe ... Sep 12
	Medvarsity Online Ltd. Partners With Singhania University to Enhance Patient Safety Training ... Sep 12
14 Stories found!